403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
The Epigenetics Market Size To Accumulate Around USD 66 Billion By 2032 Driven By Advancements In Personalized Medicine & Cancer Diagnostics
| Report Attributes | Details |
| Market Size in 2023 | US$ 15.2 billion |
| Market Size by 2032 | US$ 66 billion |
| CAGR | CAGR of 17.7% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Regional Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East]), Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Key Growth Drivers | Advancements in personalized medicine, cancer research, and increasing investments in epigenetic technologies. |
Segment Analysis
By Product
In 2023, reagents held a global market share of over 33%. That is due to the fact most research in epigenetics is centered on histone and DNA modifiers. The reagents are essential for understanding and manipulation of epigenetics for use in research and therapeutics. Key players like Promega Corporation not only provide a plethora of reagents but also provide stability and streamline customer flow.
The services segment is expected to register the highest CAGR during the forecast period. Epigenetics involves the sequencing, analysis, and consultation of microscopic data sets, and epigenetics services can get costly using high-tech like ChIP-seq and bisulfite sequencing. Demand for epigenetics services is important for research institutes, as they usually do not have any laboratory facilities for such analysis.
By Technology
In 2023, DNA methylation was the largest contributor and generated over 44% of worldwide revenues. This is due to its essential role in regulating gene expression and its relevance in elucidating disease mechanisms, such as cancer. There are opportunities for the use of DNA methylation in precision medicine.
Among segments, the Histone Acetylation segment is anticipated to grow with the highest CAGR of 18% during the estimated period from 2024 to 2032. This growth is being driven by advancements in methods and a well-established scientific basis for therapeutic benefits. Based on the above distinction, histone acetylation technologies are being more widely used in clinical and research settings, especially in treating solid tumors, leukemia, and inflammation.
By End-Use
Academic research remained the largest application area in 2023, accounting for over 36% of revenue share. Epigenetic mechanisms were discovered to be extremely complex and to have high applicability in medicine and genetics, this moved research activities to the universities.
The presence of the clinical research market in the epigenetic market is expected to grow by 17% in the forecast period due to its significance of being able to provide information regarding the epigenetics involved in discovering new therapeutic targets and personalized medicines.
Need any customization research on Epigenetics Market, Enquire Now@
Epigenetics Market Key Segmentation:
By Product
- Reagents Kits
- ChIP sequencing kit Whole Genomic Amplification kit Bisulfite Conversion kit RNA sequencing kit Others
By Application
- Oncology
- Solid tumors Liquid tumors
- Inflammatory diseases Metabolic diseases Infectious diseases Cardiovascular diseases Others
By Technology
- DNA Methylation Histone Methylation Histone Acetylation Large non-coding RNA MicroRNA modification Chromatin structures
By End-use
- Academic Research Clinical Research Hospitals & Clinics Pharmaceutical & Biotechnology Companies Others
Regional Analysis
North America dominated the epigenetics market in 2023, holding the largest revenue share. Its leadership is attributed to the prevalence of sophisticated healthcare infrastructures, which have attracted huge government funding for genomic research, as well as to the prevalence of major players in the market. The United States leads the market, driven by extensive research activities, high levels of adoption of advanced technologies, and a solid pipeline of epigenetic drugs. The rising cancer and chronic disease cases boost the demand for epigenetics-based diagnostics and therapeutics in the region.
Recent Developments
- In July 2023, Chroma Medicine, Inc. and Sangamo Therapeutics, Inc. entered into a licensing agreement to develop epigenetic medicines with zinc finger proteins that can specifically recognize DNA sequences. In April 2023, the National Cancer Center and Eisai announced a collaboration to advance clinical studies of the anticancer agent tazemetostat.
Buy a Single-User PDF of Epigenetics Market Analysis & Outlook Report 2024-2032@
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
7. Epigenetics Market Segmentation, by Product
8. Epigenetics Market Segmentation, by Application
9. Epigenetics Market Segmentation, by Technology
10. Epigenetics Market Segmentation, by End-use
11. Regional Analysis
12. Company Profiles
13. Use Cases and Best Practices
14. Conclusion
Access Complete Report Details of Epigenetics Market Analysis & Outlook 2024-2032@
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy ... Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment